Skip to content

Author

Asimina S. Courelli

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Patient-Derived 3D Cell Models as New Approach Methodologies: Applications, Advances, and Challenges for Increased-Throughput Assays.

Patient-derived three-dimensional (3D) cell models are new approach methodologies (NAMs) that bridge the gap between traditional 2D cell cultures and in vivo models, making them attractive for increased-throughput screening (ITS) and secondary assays. In this review, we outline screening applications implementing patie...

Asimina S. Courelli, M. Macdonald, Hervé Tiriac · 0 citations
Sep 2026

Abstract B137: Targeting MICAL2 sensitizes pancreatic cancer cells to gemcitabine and enhances therapeutic response

Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy, largely due to rapid development of resistance to standard chemotherapies such as gemcitabine. MICAL2 is a redox-dependent regulator of actin dynamics that is overexpressed in PDAC, but its role in therapeutic resistance remains poorly un...

Ponmathi Panneerpandian, Kevin Christian Montecillo Gulay, M. Macdonald et al. · 0 citations
Sep 2026

Abstract A054: MICAL2 promotes oncogenic Kras -induced pancreatic cancer initiation by regulating RAC1-mediated acinar to ductal metaplasia

Pancreatic ductal adenocarcinoma (PDAC) is a deadly form of pancreatic cancer with the poorest 5-year survival rate among all solid cancers. Therefore, identifying effective therapeutic strategies is crucial for treating this disease. Using a genome-wide screening approach to find novel and targetable factors in huma...

Nirakar Rajbhandari, Deepa Sheik Pran Babu, E. Mose et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.